Acadia Healthcare Company, Inc. with ticker code (ACHC) now have 12 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range between the high target price and low target price is between $78.00 and $43.00 suggesting an average analyst share price target price of $60.67. (at the time of writing). Now with the previous closing price of $37.90 this indicates there is a potential upside of 60.1%. The 50 day MA is $44.07 while the 200 day moving average is $64.26. The company has a market cap of 3.48B. Currently the stock stands at: $37.50 USD
The potential market cap would be $5,575,575,205 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 12.3, revenue per share of $34.13 and a 6.06% return on assets.
Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services across the United States. The Company is focused on acquiring and developing behavioral healthcare facilities. The Company is engaged in developing and operating inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States. Its facilities that offer acute care services provide evaluation and crisis stabilization of patients with severe psychiatric diagnoses through a medical delivery model that incorporates structured and intensive medical and behavioral therapies with 24-hour monitoring by a psychiatrist, psychiatric trained nurses, therapists and other direct care staff. Its specialty treatment facilities include residential recovery facilities and eating disorder facilities.
